VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 138 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282,294 | -77.8% | 36,425 | -67.2% | 0.00% | -83.3% |
| Q2 2023 | $1,271,053 | +48.8% | 111,009 | +0.2% | 0.01% | +20.0% |
| Q1 2023 | $854,407 | +20.3% | 110,818 | -4.8% | 0.01% | +25.0% |
| Q4 2022 | $710,071 | +6.9% | 116,405 | +3.8% | 0.00% | 0.0% |
| Q3 2022 | $664,000 | -6.6% | 112,155 | -6.7% | 0.00% | 0.0% |
| Q2 2022 | $711,000 | -30.2% | 120,231 | -10.0% | 0.00% | -20.0% |
| Q1 2022 | $1,018,000 | +154.5% | 133,572 | -9.5% | 0.01% | +150.0% |
| Q4 2021 | $400,000 | +370.6% | 147,534 | +359.2% | 0.00% | – |
| Q3 2021 | $85,000 | -64.9% | 32,130 | +21.7% | 0.00% | -100.0% |
| Q1 2020 | $242,000 | -26.9% | 26,400 | +11.1% | 0.00% | 0.0% |
| Q4 2019 | $331,000 | – | 23,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |